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Abstract A 12 kb haplotype upstream of the key signal-
ing protein gene, AKT1, has been associated with insulin
resistance and metabolic syndrome (Devaney et al. 2010).
The region contains the Wrst exon and promoter sequences
of AKT1, but also includes the complete transcript unit
for a highly conserved yet uncharacterized zinc Wnger-
containing protein (ZBTB42). One of the component SNPs
of the 12 kb haplotype metabolic syndrome haplotype
changes a conserved amino acid in the predicted ZBTB42
protein, increasing the potential signiWcance of the
ZBTB42 transcript unit for contributing to disease risk.
Using RT-PCR of human and mouse cells, we veriWed that
the two exon ZBTB42 was expressed and correctly spliced
in human skeletal muscle, and murine C2C12 cells. Pro-
duction of peptide antibodies showed the expected protein
in human (47 kD) and mouse (49 kD) immunoblots, and
murine tissue distribution showed strongest expression in
muscle and ovary. Immunostaining showed nuclear locali-
zation of the ZBTB42 protein in human muscle. Confocal
imaging analyses of murine muscle showed ZBTB42
distributed in the nucleoplasm, with particular enrichment
in nuclei underlying the neuromuscular junctions. The
genetic association data of metabolic syndrome, coupled
with the molecular characterization of the ZBTB42 tran-
script unit and encoded protein presented here, suggests
that ZBTB42 may be involved in metabolic syndrome
phenotypes.
Introduction
We recently reported the discovery of three SNPs present
in high LD in highly conserved regions within and
upstream of AKT1 (Devaney et al. 2010). The H1 haplo-
type is composed of the three ancestral alleles at the three
loci. As expected this is the predominant haplotype in
most populations. The H2 haplotype is composed of the
three derived alleles at the loci. We have genotyped indi-
viduals from multiple American populations and found
high frequencies of H2, ranging from 10 to 35.6%. The
lack of intermediate haplotypes (a mix of alleles from H1
and H2) suggests that the H2 haplotype may confer some
advantage to the individuals carrying it enforcing its inheri-
tance as a haplotype block.
Due to its role as a mediator of the insulin response path-
way as well as a regulator of muscle hypertrophy and mus-
cle atrophy (Bodine et al. 2001; Elghazi et al. 2006; Nader
2005; Zdychova and Komers 2005), we genotyped the H1
and H2 haplotype tagging SNP rs1130214 in four popula-
tion-based cohorts as a candidate gene for metabolic risk
phenotypes (Devaney et al. 2010). These included the
FAMUSS study of college-aged individuals (mean age
23.7 years) who participated in supervised resistance train-
ing sessions on their non-dominant arm (Thompson et al.
2004); the SHS, a group of 2,134 middle aged (mean age
55.5 years) Native Americans from eight diVerent popula-
tions within the United States (Lee et al. 1990); the Health
ABC Study of older individuals (mean age 73 years) with
the goal of studying the eVects of age on a number of health
indicators including cardiovascular health and development
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434 Hum Genet (2011) 129:433–441of metabolic syndrome and T2D (Visser et al. 1999); and
the STRRIDE Study, which was developed to study the
eVect of aerobic exercise on individuals expressing the
endophenotypes of metabolic syndrome (Slentz et al.
2004). We found signiWcant associations with all four
cohorts with H2: lower fasting glucose levels in young
females (FAMUSS), lower BMI and higher LDL levels in
middle-aged females (SHS), lower 2 h fasting glucose lev-
els and lower fasting insulin in middle-aged males (SHS);
lower fasting glucose levels in older males (Health ABC)
and higher Sg levels in middle aged European Americans
(STRRIDE) (Devaney et al. 2010). H2 was strongly associ-
ated with overall risk of developing metabolic syndrome
in older subjects of the Health ABC study. H2 conferred
a 40% risk reduction for the development of metabolic
syndrome.
The 12 kb haplotype contained three component SNPs,
with the common haplotype (H1) showing the ancestral
allele at each position. These SNPs were found to have func-
tional relevance to gene expression; promoter assays con-
taining either allele has shown a strong tissue-speciWc eVect
on gene expression (Harmon et al. 2010). One of the SNPs
of the H1/H2 haplotype is present 12 kb upstream of AKT1
in the putative coding region of an uncharacterized gene,
zinc Wnger and BTB domain containing 42 (ZBTB42). This
transcript is predicted to contain 2 exons, and is highly con-
served through multiple species down to the stickleback Wsh.
However, there has been very little EST evidence in support
of gene expression and splicing of this transcript unit, and
the putative protein product has not been characterized. Our
interest in the AKT1 H2 haplotype and its strong phenotypic
associations in variable populations drew our attention to the
characterization of this gene and protein.
We describe the characterization of ZBTB42 as a mem-
ber of the C2H2 zinc Wnger protein family. Zinc Wnger pro-
teins are classiWed by the presence of zinc Wnger domains,
which bind to target DNA sequences and regulate transcrip-
tion. ZBTB42 is expressed in skeletal muscle, and localized
to the myoWber nuclei.
Materials and methods
AmpliWcation of ZBTB42 in human and mouse cDNA
Total RNA was extracted from 50 to 100 mg of human
skeletal muscle using TRIzol reagent (Invitrogen Corpora-
tion, Carlsbad, CA, USA) and cleaned using RNeasy RNA
cleanup kit (Qiagen, Valencia, CA, USA). Complementary
DNA was reverse transcribed from 1 ug of mRNA using a
cDNA synthesis kit and oligo(dT) primers according to the
manufacturer’s protocol (Invitrogen Corporation, Carlsbad,
CA, USA).
PCR was performed using a forward and reverse custom
primer designed to cover the Wrst intron in human ZBTB42
causing genomic and cDNA amplicons to be diVerent in
size (5’-CGGCGACCGGAGAGGAGCTC-3, 5-CTTCA
ACGACAGGTCCAGGG-3). Accuprime Taq polymerase
(Invitrogen Corporation, Carlsbad, CA, USA) was added to
the template along with buVer and the ZBTB42-speciWc
primers. The samples were then heat activated at 94°C and
cycled between denaturation (94°C for 30 s), annealing
(60°C for 30 s) and extension (68°C for 1 min) 30 times.
PCR products were size-separated by gel electrophoresis
using a 1% agarose gel and were visualized through ethi-
dium bromide chelation of the DNA under UV.
Custom primers (5-GCAGTGTCTACTTCCATCTC-3,
5-CACTTGACTGCTCTGCAACC-3) were designed
against the mouse homolog to ZBTB42 (mZbtb42) for PCR
ampliWcation using a panel of cDNAs from various mouse
tissues (Clontech, Mountain View, CA, USA). Gel electro-
phoresis was used to verify expression and the size of the
product.
DNA sequencing
SpeciWc primer pairs encompassing the ZBTB42 gene were
used to sequence the ampliWed product described above
(5-CGGCGACCGGAGAGGAGCTC-3, 5-CTTCAACG
ACAGGTCCAGGG-3). Sequencing was done using the
BigDye Terminator version 3.1 Cycle Sequencing Kit and
the 3130xl Genetic Analyzer according to the manufac-
turer’s instructions (Applied Biosystems). Nucleotide
changes were identiWed by aligning sequences generated
from both primers (forward and reverse) for comparison
with corresponding sequences available in Genbank using
SEQUENCHER 4.0.2 analysis software.
IdentiWcation of putative ORF and functional domains
The sequence of the coding region of ZBTB42 from the
Genome Browser (University of California Santa Cruz)
was input into ORFinder (NCBI) to identify the longest
open reading frame. The predicted protein sequence was
then input into ScanProsite (Swiss Institute of Bioinformat-
ics) to scan the amino acid sequence for any recognizable
databased protein domains.
Antibody production
Unique peptide sequences were Wltered from the ORF of
ZBTB42. Final peptide selection was based on values of
antigenicity, hydrophilicity and surface probability
(GRLQEKDRSLDPGN, DLSLKSGPRQERVH). Custom
polyclonal antibodies were produced in two rabbits against
the two unique peptides (for a total of four antibodies)123
Hum Genet (2011) 129:433–441 435through Invitrogen’s custom antibody service. The immune
sera were aYnity puriWed using immobilized peptides. The
antibody is available upon request.
Western blot
Protein was extracted from C2C12 cells; (mouse myoblasts
grown in 40 cm Xasks in Dulbecco’s ModiWed Eagle’s
Medium (Hyclone, Logan, UT, USA) with 10% FBS and
1% penicillin and streptomycin). Radioimmuno precipita-
tion assay (RIPA) cell lysis and extraction buVer (contain-
ing DTT, and the protease inhibitors pepstatin, PMSF,
antipain, and leupeptin), was used to harvest protein from
C2C12 cells.
Protein from human skeletal cells was harvested from
muscle sections. Muscle biopsies were sectioned using a
cryostat at ¡20°C. RIPA lysis buVer was used to lyse the
cells and the proteins were then isolated using centrifuga-
tion at 13,000 rpm for 15 min. A 2-month-old female black/
6 mouse was sacriWced and tissues were harvested. Tissues
were homogenized in RIPA lysis buVer using a tabletop
homogenizer. Total protein extract was then isolated using
centrifugation.
Total protein in each sample was quantiWed using the
colorimetric assay RC DC Protein Assay (BioRad, Hercules,
CA, USA) and BSA standards from 0 mg/ml to 10 mg/ml.
20 g of protein was loaded for each sample in a
NuPAGE® Novex 4–12% Bis–Tris Gel (Invitrogen, Carls-
bad, CA, USA). The proteins were then transferred to a
nitrocellulose membrane, blocked with 5% milk and incu-
bated overnight with our custom antibody AX-1#3 against
peptide DLSLKSGPRQERVH. Washes were done with 5%
milk in TBST. The membrane was then incubated with
HRP-tagged goat anti-rabbit secondary antibodies. ECL
detection reagents (Amersham pharmacia biotech) were
used to detect the HRP and the membrane was exposed to
Wlm.
Immunohistochemistry
Muscle sections were cut 10 m thick laterally at the belly
of frozen human skeletal muscle biopsies in a cryostat set at
¡20°C. The sections were arranged on Superfrost glass
slides and allowed to air-dry overnight. The sections were
blocked with 5% horse serum and then incubated with our
custom antibody AX-1#3 (from rabbit) and anti-merosin
(from mouse) for 2 h. The excess primary antibodies were
removed by three Wve-minute washes with PBS. The sec-
tions were incubated with the secondary antibodies: anti-
rabbit Cy3 and anti-mouse Cy2. The sections were treated
with the nuclear stain DAPI. Sections were covered and
visualized on an apotome microscope as individual stains
and merged images.
For confocal microscopy, mouse gastrocnemius muscle
was Wxed in situ with 2% paraformaldehyde at the time of
dissection and stored in 10% sucrose/PBS at 4°C. Gastroc-
nemius muscle was teased apart into small Wber bundles
and incubated in block and permeabilization buVer (0.5%
TritonX®-100, 0.1% Tween 20, 2% BSA, 20% goat-horse
serum blend in PBS) overnight at 4°C. Fibers were incu-
bated in custom aYnity puriWed antibody AX-1#3 (1:500
dilution in antibody buVer: 0.2% TritonX®-100, 0.1%
Tween 20, 2% BSA in PBS) for 2 h with gentle mixing.
Fibers were centrifuged at 4,000£g for 1 min then washed
with 0.1% Tween-20/PBS, repeating this cycle three times.
Fibers were incubated with secondary antibody (Alexa
Fluor® 555 F(ab)2 fragment of goat anti-rabbit IgG)
(H+L)(1:500 in antibody buVer) (Invitrogen, Carlsbad, CA,
USA) for 2 h and washed three times as stated above.
Fibers were counterstained with Alexa Fluor® 488 -bun-
garotoxin conjugate and DAPI to label neuromuscular junc-
tions and nuclei respectively and washed three more times
(Invitrogen, Carlsbad, CA, USA). Fibers were left in wash
buVer overnight at 4°C with gentle mixing then mounted in
Fluoromount-G (Southern Biotech, Birmingham, Alabama)
the following day. Confocal laser-scanning microscopy was
performed using a Carl Zeiss LSM 510 laser scanning
microscope coupled to Zen LE microscopy software (Carl
Zeiss, Germany).
Results
ZBTB42 is expressed as a transcript in human skeletal 
muscle cDNA
ZBTB42 is predicted to contain two exons and a single
intervening intron according to limited EST evidence on
the UCSC genome browser. To determine if ZBTB42 is
transcribed into a full length mRNA in vivo, we attempted
to amplify the transcript using RT-PCR with ZBTB42-spe-
ciWc primers in human skeletal muscle. The PCR primers
were designed against the two exons; the forward primer in
exon 1, the reverse primer in exon 2. The primers cover
intron 1, therefore allowing us to diVerentiate cDNA
(introns spliced out) from genomic DNA (containing
introns), which was included as a control. The expected
size products between the two primers are 600 bps for
cDNA and 1,500 bps for genomic DNA. The genomic sam-
ple showed one band at 1,500 bp corresponding to the non-
spliced genomic locus. The cDNA showed a band at
600 bp, corresponding to the predicted size between the
primers. There are other larger bands that were ampliWed in
the cDNA sample, including one at 1,500 bp, which is
probably genomic DNA contamination from the mRNA
isolation and cDNA synthesis steps (Fig. 1). This indicated123
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human skeletal muscle.
To conWrm that the cDNA PCR product was ZBTB42
and not a non-speciWc binding event, we eluted the 600 bp
product from the gel and sequenced it. The sequence
matched the sequence of ZBTB42 from the UCSC genome
browser database.
ZBTB42 has C2H2 zinc Wnger domains and an N-terminal 
POZ domain
Upon sequence investigation using online protein predic-
tion tools (ORFinder, ScanProsite), the predicted primary
structure of the protein translated from ZBTB42 shows four
zinc Wnger domains at its C-terminus, which are highly
homologous with other members of the C2H2 class of zinc
Wnger proteins. In addition, there is a POZ domain (named
for its prevalence in POxvirus proteins and Zinc Wnger pro-
teins) at the N-terminus of the protein, which is common to
most members of the C2H2 family of proteins (Fig. 2). The
predicted size of the protein using the amino acid sequence
from ORFinder is 47 kDa. Upon comparison with the
mouse homolog, Zbtb42, we observed that the two proteins
share 75% amino acid identity at the protein level, with
94% amino acid identity in the zinc Wnger and POZ
domains. These analyses indicated that ZBTB42 would be
an expressed protein.
ZBTB42 is translated into a protein in human skeletal 
muscle
To directly identify whether ZBTB42 is an expressed protein
in vivo we produced two antibodies against two distinct pep-
tide sequences near the predicted N-terminus (Fig. 2). The
peptides were designed to exclude the POZ and zinc Wnger
functional domains due to anticipated cross-reaction with
other zinc Wnger domain and POZ domain-containing pro-
teins (amino acids 189–202 [DLSLKSGPRQERVH] and
116–129 [GRLQEKDRSLDPGN]).
Each of the four antibody preparations was tested by
immunoblot using human skeletal muscle lysates as well as
lysates from C2C12 mouse myoblasts. The antibody
against peptide DLSLKSGPRQERVH from rabbit #3 (AX-
1#3) showed the best speciWcity and sensitivity for the pre-
dicted 47 kDa protein in both the human skeletal muscle
and mouse myoblasts (Fig. 3). The antibodies raised against
GRLQEKDRSLDPGN were non-speciWc as evidenced by
large amount of non-speciWc binding in the immunoblot
analysis of human skeletal muscle lysates and C2C12
lysates. We also observed a second band at 36 kDa in the
human protein lysates. This may be a splice variant or reX-
ect non-speciWc binding of another protein. The immuno-
blot analysis provided strong evidence that this protein is
not only transcribed into an mRNA in vivo but is also trans-
lated as a protein in human skeletal muscle.
Fig. 1 ZBTB42 cDNA is expressed in human skeletal muscle. a shows
a schematic of the ZBTB42 gene. The black boxes represent the two ex-
ons of ZBTB42. The line with arrow heads is the intronic region and
shows the direction of the gene. The black arrows above the gene are
the forward and reverse primers used to amplify the transcript. The
primers were designed across the intron, in exons 1 and 2, to distin-
guish between genomic DNA (1,500 bp) and cDNA (600 bp). b shows
the ampliWcation of ZBTB42 from human cDNA and genomic DNA.
cDNA was reverse transcribed from total RNA isolated from a frozen
human skeletal muscle biopsy (lane 3). Genomic DNA (lane 2) was
isolated from human skeletal muscle. cDNA was ampliWed at the cor-
rect size of 600 bp. There are additional bands in the cDNA sample
including one at 1,500 bp. This may be genomic DNA contamination.
PCR products were loaded in a 1% agarose gel for size discrimination.
A 100 bp marker was used for size comparison (lane 1)123
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of mouse tissues
A panel of murine tissues was tested by immunoblot using
our AX-1#3 antibody, and a loading control (vinculin)
(Fig. 4). The murine orthologue of ZBTB42, Zbtb42, was
detected at the expected 47 kDa molecular weight, and
showed highest expression in skeletal muscle and ovary, as
well as C2C12 cell line myotubes. Low expression was
seen in brain, lung, spleen, liver and heart. The kidney and
intestines do not express mZbtb42. The liver and skeletal
muscle showed strong expression of a smaller protein prod-
uct (36 kDa), which may be a splice variant of mZbtb42
speciWc to these tissues.
ZBTB42 localizes to the nucleus in skeletal muscle, 
with enrichment at neuromuscular junction nuclei
Zinc Wnger proteins typically localize to the nuclei of cells
and function as transcription factors when the zinc Wnger
domains bind to DNA targets to initiate transcription (Iuchi
2001). To evaluate cellular localization we co-stained
human skeletal muscle cross sections with an antibody
against ZBTB42 (AX-1#3), and an antibody against mero-
sin, which is a muscle cell membrane protein (Fig. 5).
ZBTB42 protein was localized to the nuclei in skeletal
Fig. 2 ZBTB42 contains C2H2 zinc Wnger domains and shares high
sequence homology with mouse. ZBTB42 is a member of the C2H2
zinc Wnger family of proteins. a The four C2H2 zinc Wnger domains of
ZBTB42 at the C-terminal and the POZ domain at the N-terminal. The
antibody AX-1#3 was designed against peptide DLSLKSGPRQERVH
(black line) present in between the conserved domains. The antibody
with non-speciWc binding (red line) was designed against peptide
GRLQEKDRSLDPGN. b The conservation of ZBTB42 (annotated as
ZBTB42) across species. ZBTB42 shares the highest level of homol-
ogy with mouse and rat sequences
Fig. 3 ZBTB42 protein is expressed in human skeletal muscle and a
murine cell line C2C12 myotubes. Immunoblot analysis with AX-1#3
shows ZBTB42 protein expression (47 kDa) in lysates isolated from
two human skeletal muscle samples sectioned from frozen biopsies
(lanes 1, 2) and mZbtb42 protein expression from two cultures of
murine cell line C2C12 myotubes (lanes 3, 4) (47 kDa). 20 g of protein
was loaded for each sample. A second band of 36 kDa is present in
human skeletal muscle, but is absent from the C2C12. There is a
double band in the C2C12 samples. This may be a splice variant or
post-translational modiWcation123
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tissue cells. The addition of 4,6-diamidino-2-phenylindole
(DAPI), a nuclear stain, veriWed that the ZBTB42 protein
was present in all nuclei (Fig. 6).
To determine the localization within nuclei, the ZBTB42
protein was studied using confocal microscopy in murine
skeletal Wxed and teased myoWbers (Fig. 7). The ZBTB42
protein was seen localized to myoWber nuclei superimposed
on the DNA chromatin (DAPI), suggesting a localization
within the nucleoplasm (Fig. 7a). MyoWbers have distinct
nuclear domains within a syncytium, with myonuclei
underlying the neuromuscular junction showing specialized
function. IdentiWcation of neuromuscular junctions (NMJs)
was done using biochemical staining for acetylcholine recep-
tors with labeled bungarotoxin, and ZBTB42 co-localized
with NMJs (Fig. 7b). This analysis showed ZBTB42 to be
highly enriched in subsynaptic nuclei at the NMJ, again
within the nucleoplasm (Fig. 7b, c).
Discussion
We recently reported strong associations between a three
SNP haplotype encompassing 12 kb upstream and inclusive
of the Wrst exon of the AKT1 gene, and containing the
ZBTB42 gene. One of the strongly linked SNPs,
rs10141867, was in the coding sequence of the ZBTB42
transcript. We show that ZBTB42 is transcribed into a
spliced mRNA in human skeletal muscle through RT-PCR.
We further demonstrated that this transcript is translated
into a 47 kD protein in vivo in human skeletal muscle
immunoblots using a custom designed antibody directed
against a unique peptide on the N-terminus of the predicted
open reading frame (ORF) of ZBTB42.
The mouse homolog mZbtb42 is homologous to
hZBTB42, sharing 94% amino acid identity in the func-
tional domains and an overall amino acid identity of 75%.
We found that the mZbtb42 protein is variably expressed in
mouse tissues, with skeletal muscle and ovaries showing
the strongest expression. Both human and mouse immuno-
blots showed some heterogeneity of protein size, with pos-
sible doublets of similar molecular weight, and also a
strong 36 kD smaller signal in murine muscle and liver
(Fig. 4). Further work is required to determine if the 36 kD
protein represents alternative processing of the mZbtb42
protein, or a cross-reactive protein speciWc to those tissues.
The predicted ORF and putative functional domains
were identiWed (virtual characterization) with the web tools
ORFinder (NCBI) and ScanProsite. The functional domains
of ZBTB42 are most similar to members of the C2H2 zinc
Wnger protein family. There are diVerent families of zinc
Wnger proteins characterized by domains at the C-terminus
that contain the amino acids cysteine and histidine in a
speciWc order to create a unique secondary structure stabi-
lized by a zinc ion bond. The C2H2 zinc Wnger proteins
have two cysteine and two histidine residues organized
CX2-4CX12HX2-6H. The C2H2 domains bind to the DNA
through a short alpha-helix domain and initiate transcription
of target genes (Chang et al. 1996; Iuchi 2001). Depending on
the number of zinc Wnger domains, they are able to bind to
diVerent sequences of DNA, RNA and, in some instances,
proteins (Chang et al. 1996; Iuchi 2001). At the N-terminal
of the ZBTB42ORF there is a POZ domain. POZ domains
Fig. 4 mZbtb42 is variably expressed in mouse tissues with strong
expression in skeletal muscle. Immunoblot analysis of lysates from a
panel of mouse tissues shows that mZbtb42 is highly expressed vari-
ably across tissues. 20 g of protein was loaded for each tissue. High
expression is seen in skeletal muscle and ovary (lanes 1, 2). Brain,
lung, spleen, liver and heart show low expression (lanes 3, 4, 8, 9, 10)
while mouse intestines and kidneys show no expression of mZbtb42
(lanes 6, 7). The skeletal muscle (lane 1) and liver (lane 9) show strong
expression of a smaller molecular weight product (36 kDa). This may
be a splice variant speciWc to those tissues, or a cross-reactive protein.
Lysates from C2C12 cells were loaded as positive controls (lanes 5,
11). Total vinculin is shown as a loading control
Fig. 5 ZBTB42 localizes to the nuclei of human skeletal muscle
Wbers. ImmunoXuorescence analysis with AX-1#3 (visualized by Cy3-
conjugated secondary antibody) of human skeletal muscle sections
(10 m) shows ZBTB42 expression exclusive to the nuclei. Sections
are cut laterally through the muscle resulting in cross-sectional view of
the muscle cells. Muscle cell nuclei are peripherally localized. The
membrane is stained with anti-merosin (visualized by Cy2-conjugated
secondary antibody). Images were taken on an apotome microscope at
100£ magniWcation123
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nuclei of human skeletal muscle 
Wbers and merges with a nuclear 
stain. ImmunoXuorescence anal-
ysis of a triple-stained muscle 
section shows nuclear localiza-
tion of ZBTB42 in skeletal mus-
cle Wbers. Sections are cut 
laterally through the muscle 
resulting in cross-sectional view 
of the muscle cells. Muscle cell 
nuclei are peripherally localized. 
a AX-1#3 stain of ZBTB42 in 
human skeletal muscle shows 
staining exclusive to the nuclei 
(Cy3-conjugated secondary anti-
body). b Anti-merosin staining 
shows expression of the mem-
brane protein, merosin (Cy2-
conjugated secondary antibody). 
c DAPI nuclear stain. d Merge 
of all three stains shows perfect 
alignment of DAPI and ZBTB42 
expression in muscle cell nuclei. 
Images were taken on an apo-
tome microscope at 40£ magni-
Wcation
Fig. 7 ZBTB42 localizes to the 
nuclei of mouse skeletal muscle 
Wbers, and is enriched at the neu-
romuscular junction. Shown is 
mouse gastrocnemius skeletal 
muscle Wber bundles stained for 
immunoXuorescence of 
ZBTB42 protein (Alexa Fluor® 
555; AX-1#3 antibody), nuclear 
DNA (DAPI), and neuromuscu-
lar junctions (Alexa Fluor® 488 
-bungarotoxin conjugate). 
a Extra-synaptic myoWber 
nuclei (absence of Alexa Fluor® 
488 -bungarotoxin signal). 
b Synaptic myoWber nuclei 
(presence of Alexa Fluor® 488 
-bungarotoxin signal). c High 
resolution superimposed image 
of the ZBTB42 protein (red), 
nuclear DNA (blue) and bunga-
rotoxin post-synaptic myoWber 
membrane (green). ZBTB42 
protein signal is seen in most 
myoWber nuclei within the 
nucleoplasm. The protein was 
highly enriched in nuclei under-
lying the neuromuscular junc-
tion123
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proteins and Zinc Wnger proteins (Albagli et al. 1995;
Bardwell and Treisman 1994; Li et al. 1999). POZ domains
function as binding mediators either by aiding homodimer-
ization or heterodimerization (Bardwell and Treisman
1994; Chen et al. 1995; Huynh and Bardwell 1998). In the
case of transcriptional regulators, such as zinc Wnger pro-
teins that contain POZ domains, these domains mediate
transcriptional repression through recruitment of co-repres-
sor proteins or by altering the binding eYciency between
the zinc Wnger domains and the target DNA (Chang et al.
1996).
The virtual evidence from ORFinder and ScanProsite
described above, by way of sequence analysis and a protein
domain database query is signiWcant but the true characteri-
zation of a protein must be done through studies of expres-
sion and other functional tests. Zinc Wnger proteins localize
to the nuclei of cells where they regulate the transcription
of target genes. Immunohistochemistry of human skeletal
muscle sections showed sensitive and speciWc binding of
ZBTB42 in the nuclei of human muscle Wbers. The staining
of ZBTB42 co-localized with the nuclear stain DAPI. Con-
focal localizations within murine muscle conWrmed nuclear
localization, with further localization within the nucleo-
plasm (co-localization with DAPI nucleic acid stain)
(Fig. 6). There are distinct nuclear domains within the syn-
cytial muscle Wbers, with nuclei underlying the neuromus-
cular junction (NMJ) having distinct transcriptional
programs. We identiWed sub-synaptic NMJ nuclei using
biochemical staining with labeled bungarotoxin, and
showed that mZbtb42 protein was highly enriched within
the nucleoplasm of NMJ nuclei (Fig. 7). These date bolster
our hypothesis that this protein has active zinc Wnger
domains and may function as a novel muscle-relevant tran-
scription factor in vivo.
As noted above, the ZBTB42 transcript unit is contained
within a 12 kb haplotype associated with insulin resistance
and metabolic syndrome (Devaney et al. 2010). The com-
ponent polymorphisms in this haplotype show strong
activity in modulating transcriptional reporter assays, and
haplotype-dependent variable transcriptional modulation of
AKT1, or ZBTB42, or both provides a potential molecular
mechanism for modulating insulin resistance (a muscle
phenotype), and metabolic syndrome (Harmon et al. 2010).
AKT1 has clear functional roles in muscle remodeling that
are likely relevant to insulin resistance and metabolic syn-
drome. The data presented here on ZBTB42 suggests that
this novel protein may also have a hitherto undiscovered
role in muscle and metabolic syndrome phenotypes.
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